Get started
Author

Yin Wan

Preoperative Factors Predict Perioperative Morbidity and Mortality After Pancreaticoduodenectomy
2011 · David Yu Greenblatt, Kaitlyn J. Kelly, et al. · Annals of Surgical Oncology · 302
Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated?
2011 · Xiao-Min Yu, Yin Wan, et al. · Annals of Surgery · 298
The Burden of Gastrointestinal Anastomotic Leaks: an Evaluation of Clinical and Economic Outcomes
2014 · Jeffrey Hammond, Sangtaeck Lim, et al. · Journal of Gastrointestinal Surgery · 270
PDF
Risk Stratification for Distal Pancreatectomy Utilizing ACS-NSQIP: Preoperative Factors Predict Morbidity and Mortality
2010 · Kaitlyn Jane Kelly, David Yu Greenblatt, et al. · Journal of Gastrointestinal Surgery · 115
Indirect costs associated with metastatic breast cancer
2013 · Yin Wan, Xin Gao, et al. · Journal of Medical Economics · 53
PDF
Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain.
2015 · Yin Wan, Shelby Corman, et al. · PubMed Central · 52
Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States
2020 · Jonathan K. Kish, Debanjana Chatterjee, et al. · Advances in Therapy · 39
PDF
Health Economic Evaluation of Patients Treated for Nosocomial Pneumonia Caused by Methicillin-resistant Staphylococcus aureus: Secondary Analysis of a Multicenter Randomized Clinical Trial of Vancomycin and Linezolid
2014 · Michael S. Niederman, Jean Chastre, et al. · Clinical Therapeutics · 35
Perioperative Safety and Volume: Outcomes Relationships in Bariatric Surgery: A Study of 32,000 Patients
2011 · Jon C. Gould, Craig K. Kent, et al. · Journal of the American College of Surgeons · 34
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis
2017 · Uwe Pelzer, Jean-Frédéric Blanc, et al. · British Journal of Cancer · 29
PDF
Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis
2014 · Michele Reni, Yin Wan, et al. · Journal of Medical Economics · 24
PDF
Laparoscopy Improves Short-term Outcomes After Surgery for Diverticular Disease
2010 · Andrew J. Russ, Kari L. Obma, et al. · Gastroenterology · 21
PDF
An Assessment of Clinically Important Differences on the Worst Pain Severity Item of the Modified Brief Pain Inventory in Patients with Diabetic Peripheral Neuropathic Pain
2018 · James Marcus, Kathryn Lasch, et al. · Pain Research and Management · 18
PDF
Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study
2015 · Yin Wan, Qiang Li, et al. · Journal of Medical Economics · 15
PDF
Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
2018 · Javier Cortes, José Pérez-García, et al. · Clinical Breast Cancer · 14
Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology Setting
2021 · Nicholas J. Vogelzang, Alisha M. Monnette, et al. · Clinical Genitourinary Cancer · 9
PDF
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
2016 · Caitlyn Solem, Ahmed Shelbaya, et al. · Neuropsychiatric Disease and Treatment · 9
PDF
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
2015 · Yin Wan, Shawn Sun, et al. · International Journal of COPD · 8
PDF
Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer
2018 · E Gabriela Chiorean, Daniel Von Hoff, et al. · Cancer Management and Research · 6
PDF
Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma
2021 · Chung-Han Lee, Yin Wan, et al. · European Urology Open Science · 4
PDF
Bleeding-Related Complications and Readmission Rates Associated With Fibrin Sealant Use in Patients Undergoing Coronary Artery Bypass Graft Surgery in the United States
2016 · Yin Wan, Sangtaeck Lim, et al. · Journal of Cardiothoracic and Vascular Anesthesia · 4
PDF
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non–Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin
2018 · Vera Hirsh, Yin Wan, et al. · Clinical Lung Cancer · 2
Indirect costs associated with metastatic breast cancer.
2012 · Yin Wan, Xin Gao, et al. · Journal of Clinical Oncology · 2
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC).
2020 · Chung-Han Lee, Yin Wan, et al. · Journal of Clinical Oncology · 1
Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).
2019 · John M. Kirkwood, Lisa A. Kottschade, et al. · Journal of Clinical Oncology · 1
Works count: 36
Citation count: 1,369
H-index: 14
I10-index: 15
Year
Topic
Type